Karolin Isaksson
1 – 10 of 77
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2026
-
Mark
Interplay between AIB1 genotypes and radiotherapy in a Swedish population-based breast cancer cohort
- Contribution to journal › Article
-
Mark
SWE-NEO : Swedish NEO-adjuvant trial comparing anti-PD-1 monotherapy to combined anti-CTLA-4/anti-PD-1 blockade in resectable stage III melanoma: study protocol for a phase III open-label multi-centre trial
- Contribution to journal › Letter
-
Mark
Five-year survival after introduction of adjuvant treatment in stage III melanoma : A nationwide registry-based study
- Contribution to journal › Article
-
Mark
Modeling anti-tumor immune responses using patient-derived melanoma organoids
- Contribution to journal › Article
-
Mark
Weight trajectories and obesity onset between 17 and 60 years of age, and cause-specific mortality: the Obesity and Disease Development Sweden (ODDS) pooled cohort study
(2026) In EClinicalMedicine
- Contribution to journal › Article
- 2025
-
Mark
Genetic determinants and clinical significance of circulating and tumor-specific levels of insulin-like growth factor binding protein 7 (IGFBP7) in a Swedish breast cancer cohort
- Contribution to journal › Article
-
Mark
A commonly inherited human PCSK9 germline variant drives breast cancer metastasis via LRP1 receptor
- Contribution to journal › Article
-
Mark
Interplay between AHR genotypes, lifestyle factors and adjuvant breast cancer treatments significantly impacts clinical outcome in a population-based cohort
- Contribution to journal › Article
-
Mark
Prognostic Differences of Adjuvant Radiotherapy in Breast Cancer Cohorts Based on PRLR Genotypes, Expression, and Transcriptional Network Regulation
- Contribution to journal › Article
-
Mark
Desmoplastic melanoma in Sweden in 2009–2022 : A population-based registry study demonstrating distinctive tumour characteristics, incidence and survival trends
(2025) In Journal of the European Academy of Dermatology and Venereology
- Contribution to journal › Article
